Free Trial

Pasithea Therapeutics (KTTA) SEC Filings & 10K Form

Pasithea Therapeutics logo
$0.72 +0.03 (+4.20%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$0.72 +0.00 (+0.28%)
As of 07/18/2025 07:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Pasithea Therapeutics SEC Filings

DateFilerForm TypeView
07/14/2025
3:30 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form PRE 14A
06/20/2025
3:15 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 424B5
06/20/2025
3:20 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
8:55 PM
Marques Tiago (Reporting)
Pasithea Therapeutics (Issuer)
Pasithea Therapeutics Corp. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
8:55 PM
Marques Tiago (Reporting)
Pasithea Therapeutics (Subject)
Pasithea Therapeutics Corp. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2025
3:36 PM
Orca Capital AG (Filed by)
Pasithea Therapeutics (Subject)
Pasithea Therapeutics Corp. (Subject)
Form SCHEDULE 13G/A
05/07/2025
4:18 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2025
8:20 AM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 424B4
05/06/2025
11:15 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form EFFECT
05/01/2025
8:27 AM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/24/2025
3:55 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2025
8:55 PM
Pasithea Therapeutics (Subject)
Pasithea Therapeutics Corp. (Subject)
STEINMAN LAWRENCE (Filed by)
Form SCHEDULE 13D/A
02/14/2025
4:50 PM
ARMISTICE CAPITAL, LLC (Filed by)
Pasithea Therapeutics (Subject)
Pasithea Therapeutics Corp. (Subject)
Form SCHEDULE 13G/A
11/26/2024
4:00 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
4:01 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 424B5
11/13/2024
3:30 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/14/2024
11:15 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form EFFECT
10/11/2024
4:12 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 424B3
09/30/2024
3:49 PM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
7:45 AM
Pasithea Therapeutics (Filer)
Pasithea Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KTTA) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners